Impact of Lecuofiltration of Packed Red Blood Cells on Different Hematological Parameters Measured by Advia 2120
Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06151977
Collaborator
(none)
500
11.9
Study Details
Study Description
Brief Summary
Parameters of lecuofiltration of packed Red blood cells.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Impact of lecuofiltration of packed Red blood cells on different hematological parameters measured by Advia 2120
Study Design
Study Type:
Observational
Anticipated Enrollment
:
500 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Impact of Lecuofiltration of Packed Red Blood Cells on Different Hematological Parameters Measured by Advia 2120
Anticipated Study Start Date
:
Jan 1, 2024
Anticipated Primary Completion Date
:
Dec 29, 2024
Anticipated Study Completion Date
:
Dec 29, 2024
Outcome Measures
Primary Outcome Measures
- Impact of lecuofiltration of packed Red blood cells on different hematological parameters measured by Advia 2120 [From 1/1/ 2024 to 29/12/2024]
Leucodepletion of packed RBC affects the different parameters of blood component as hemoglobin, platelets , WBCs and so on. Measurement will be done by ADIA2120 hematological analyzer by taking a sample from the packed RBC before and after leucodepletion to compare the difference in hematological parameters.
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 59 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
packed RBC ADIA2120
Exclusion Criteria:
- Whole blood
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Assiut University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
Responsible Party:
Yasmin Mohamed Sayed,
Doctor Yasmin,
Assiut University
ClinicalTrials.gov Identifier:
NCT06151977
Other Study ID Numbers:
- Leucodepleted blood parameters
First Posted:
Nov 30, 2023
Last Update Posted:
Nov 30, 2023
Last Verified:
Nov 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No